Feb 01, 2013, 08.24 AM | Source: Moneycontrol.com
On January 31, 2013 Serum Institute of India Limit bought 308,416 shares of Panacea Biotec at Rs 120.49 on the NSE.
In the previous trading session, the share closed at Rs 133.95, up Rs 19.10, or 16.63%. It touched an intraday high of Rs 137.80 and an intraday low of Rs 113.20.
The share touched its 52-week high Rs 149.75 and 52-week low Rs 63.50 on 17 September, 2012 and 04 June, 2012, respectively. Currently, it is trading 10.55% below its 52-week high and 110.94% above its 52-week low. Market capitalisation stands at Rs 820.45 crore.
The company Wednesday received the US Food and Dru
The company has also received a notification from
Panacea Biotec announces that United States Food a
US FDA gave a clearance to the company's drug Riza